To examine inter-subject variations of optimal late arterial phase contrast-enhancement defined as the greatest difference in contrast attenuation of hepatocellular carcinoma (HCC) compared to background liver parenchyma resp. pancreatic lesions compared to pancreatic parenchyma. To evaluate which time-points best depict an optimal late arterial phase.
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Peak enhancement values measured in Hounsfield units(HU) in abdominal aorta.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in abdominal aorta.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in celiac trunc.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in celiac trunc.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in superior mesenteric artery (SMA).
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in superior mesenteric artery (SMA).
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in hepatic artery.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in hepatic artery.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in portal vein.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in portal vein.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in pancreas parenchyma.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in pancreatic lesions.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in pancreas parenchyma.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in pancreatic lesions.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in liver parenchyma.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement values measured in Hounsfield units(HU) in hepatic lesions.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in liver parenchyma.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
Peak enhancement times measured in seconds in hepatic lesions.
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
highest enhancement difference between a hepatic lesion and background liver parenchyma
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
time-point of highest enhancement difference between a hepatic lesion and background liver parenchyma
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
highest enhancement difference between a pancreatic lesion and background pancreatic parenchyma
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)
time-point of highest enhancement difference between a pancreatic lesion and background pancreatic parenchyma
Timeframe: at the time of intervention (= Multi-phasic CT scan of the abdomen)